Rüedi Xylo PLUS Nasenspray
Rüedi Xylo PLUS Nasenspray is a medicine authorised by Swissmedic under authorisation number 67180. The authorisation holder is Spirig HealthCare AG. The medicinal product code is Synthetic medicines and the dispensing category is D: Supplied in pharmacies and drugstores after specialist advice, without a prescription. First authorisation was granted on 08 January 2020 and the authorisation is valid without a time limit. ATC code R01AB06 places the medicine in the group Nasal preparations.
| Authorisation number | 67180 |
|---|---|
| Name | Rüedi Xylo PLUS Nasenspray |
| Full name | Rüedi Xylo PLUS Nasenspray, Lösung |
| Authorisation holder | Spirig HealthCare AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | D · No prescription, with advice |
| ATC code | R01AB06 |
| First authorisation | 08 January 2020 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 2 | Rüedi Xylo PLUS Nasenspray, Lösung | D | 08 January 2020 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 10 | ml | R01AB06 | 12.02.2. | D |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Rüedi Xylo PLUS Nasenspray authorised in Switzerland?
Yes. Rüedi Xylo PLUS Nasenspray is authorised by Swissmedic under authorisation number 67180, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Rüedi Xylo PLUS Nasenspray have?
Rüedi Xylo PLUS Nasenspray is in dispensing category D. Supplied in pharmacies and drugstores after specialist advice, without a prescription.
Who is the authorisation holder of Rüedi Xylo PLUS Nasenspray?
The authorisation holder is Spirig HealthCare AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.